[2] Nakamura S，Nouso K， Sakaguchi K， et al.Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size[J].Am J Gastroenterol， 2006， 101(9): 2038-2043.
[2] Yamamoto K，Imamura H，Matsuyama Y，et al.Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy[J].Ann Surg Oncol，2009，1 6(10): 2795-2804.
[3] Leerapun A，Suravarapu SV，Bida JP，et al.The utility of AFPL3% in the diagnosis of hepatocellular carcinoma: evaluation in A U.S.referral population[J].Clin Gastroenterol Hepatol，2007，5 (3): 394-402.
[4] Yamamoto K， Imamura H，Matsuyama Y，et al.AFP，AFP-L3， DCP， and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC[J].J Gastroenterol，2010，45 (12): 1272-1282.
[5] Durazo FA， Blatt LM， Corey WG， et al.Des-gammacarboxyprothrombin， alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis，cirrhosis and hepatocellular carcinoma [J].Gastroenterol Hepatol，2008，2 3(10): 1541-1548.
[6] Omata M，Lesmana LA，Tateishi R，et al.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma[J].Hepatology International， 2010， 4(2): 439-474.
[7] Trinchet JC，Chaffaut C，Bourcier V，et al.Ultraonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3-and 6-month periodicities[J].Hepatology，2011，5 4(6): 1987-1997.
[8] Zinkin NT，Grall F，Bhaskar K，et al.Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease [J].Clin Cancer Res， 2008，1 4(2): 470-477.
[9] Tateishi R，Yoshida H，Matsuyama Y， et al.Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review [J].Hepatol Int，2008，2 (1): 17-30.
[10] Farinati F，Marino D，de Giorgio M，et al.Diagnostic and prognostic role of -fetoprotein in hepatocellular carcinoma: both or neither[J].Am J Gastroenterol， 2006，1 01(3): 524-532.
[11] Toyoda H，Kumada T，Tada T，et al.Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein ＜ 20 ng / ml[J].Cancer Sci，2011， 102(5): 1025-1031.